Bergman & Beving Logo

Bergman & Beving

Acquires and develops niche companies with solutions for the industrial and construction sectors.

BERG | ST

Overview

Corporate Details

ISIN(s):
SE0000101362 (+7 more)
LEI:
549300RC0HUZSJYJO751
Country:
Sweden
Address:
Box 10024, 100 55 Stockholm
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Bergman & Beving is an industrial technology group, founded in 1906, that acquires and develops leading companies within specialized niche markets. The group's core strategy involves long-term, or 'eternal,' ownership, fostering the growth of its portfolio companies as independent entities. These subsidiaries are organized into three divisions, delivering productive, safe, and sustainable solutions and products primarily for the industrial and construction sectors. The company operates on a decentralized model, described as 'small-scale enterprise on a large scale,' which empowers its subsidiaries to maintain their entrepreneurial drive while leveraging the resources of the parent group.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-28 18:00
Post-Annual General Meeting Information
Annual General Meeting of Bergman & Beving AB (publ) held 28 August 2025
English 48.5 KB
2025-08-28 18:00
Post-Annual General Meeting Information
Årsstämma i Bergman & Beving AB (publ) den 28 augusti 2025
Swedish 49.2 KB
2025-07-18 14:00
Pre-Annual General Meeting Information
Notice of Bergman & Beving’s Annual General Meeting on 28 August 2025
English 83.2 KB
2025-07-18 14:00
Pre-Annual General Meeting Information
Kallelse till Bergman & Bevings årsstämma den 28 augusti 2025
Swedish 83.5 KB
2025-07-16 07:45
Quarterly Report
Swedish 668.8 KB
2025-07-16 07:45
Earnings Release
English 842.2 KB
2025-06-30 14:00
Annual Report (ESEF)
Swedish 3.6 MB
2025-06-30 14:00
Annual Report (ESEF)
Swedish 3.6 MB
2025-06-04 09:00
M&A Activity
Bergman & Bevings avyttring av Skyddas nordiska verksamhet till Ahlsell slutförs
Swedish 42.4 KB
2025-06-04 09:00
M&A Activity
Bergman & Beving’s divestment of Skydda’s Nordic operations to Ahlsell will be …
English 42.5 KB
2025-05-09 07:45
Earnings Release
Swedish 701.8 KB
2025-05-09 07:45
Earnings Release
English 878.0 KB
2025-02-05 07:45
Earnings Release
Swedish 744.7 KB
2025-02-05 07:45
Quarterly Report
English 969.6 KB
2024-09-16 10:28
Major Shareholding Notification
Swedish 35.0 KB

Automate Your Workflow. Get a real-time feed of all Bergman & Beving filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Bergman & Beving via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-12-16 Fredrik Börjesson Other Buy 60 17,859.00 SEK
2024-12-16 Fredrik Börjesson Other Buy 60 17,790.00 SEK
2024-12-16 Malin Nordesjö Other Buy 60 17,730.00 SEK
2024-10-30 Magnus Söderlind Other Buy 3,300 1,005,840.00 SEK
2024-10-30 Peter Schön Other Buy 500 153,750.00 SEK
2024-10-29 Peter Schön Other Buy 950 291,697.50 SEK
2024-09-17 Mats Gullbrandsson Other Sell 7,248 2,095,396.80 SEK
2024-09-16 Mats Gullbrandsson Other Buy 15,000 2,959,500.00 SEK
2024-09-16 Mats Gullbrandsson Other Sell 7,752 2,259,320.40 SEK
2024-08-14 Per Martin Lundberg Other Sell 3,492 1,026,648.00 SEK

Peer Companies

Company Country Ticker View
1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea 394800
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea 174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea 203400
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea 298380
Acticor Biotech Logo
Clinical-stage biopharma developing a first-in-class drug for thrombotic diseases like stroke.
France ALACT
Adecco Group AG Logo
Global talent solutions firm offering staffing, placement, career transition, and tech consulting.
Switzerland ADI1
ADforus Co., Ltd. Logo
Ad-tech firm with AI platforms for mobile marketing and publisher monetization solutions.
South Korea 397810
Adocia Logo
Biotech improving protein drug formulations for diabetes & obesity and developing cell therapies.
France ADOC
ad pepper media International N.V. Logo
Global performance marketing & audience targeting solutions for advertisers and agencies worldwide.
Germany APM

Talk to a Data Expert

Have a question? We'll get back to you promptly.